Lineage Cell Therapeutics In shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Springbok Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $24k | 15k | 1.58 |
| 2023-03-31 | $25k | 17k | 1.50 |
| 2022-09-30 | $13k | 12k | 1.13 |
| 2021-03-31 | $41k | 18k | 2.34 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management